tiprankstipranks
Ikena Oncology (IKNA)
NASDAQ:IKNA
US Market
Holding IKNA?
Track your performance easily

Ikena Oncology (IKNA) Income Statement

97 Followers

Ikena Oncology Income Statement

Last quarter (Q3 2024), Ikena Oncology's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Ikena Oncology's net income was $-10.23M. See Ikena Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 658.00K$ 9.16M$ 15.62M$ 30.98M$ 9.19M$ 13.75M
Cost of Revenue
------
Gross Profit
$ 658.00K$ 9.16M$ 15.62M$ 30.98M--
Operating Expense
$ 69.02M$ 84.58M$ 86.52M$ 65.12M$ 53.71M$ 32.24M
Operating Income
$ -68.36M$ -75.42M$ -70.90M$ -34.14M$ -44.52M$ -18.49M
Net Non Operating Interest Income Expense
$ 2.84M$ 7.11M$ 2.15M$ 23.00K--
Other Income Expense
$ 1.20M$ 7.09M$ 2.14M$ -23.00K$ 263.00K$ 1.68M
Pretax Income
$ -59.66M$ -68.33M$ -68.77M$ -34.12M$ -44.26M$ -16.82M
Tax Provision
$ -63.00K$ -162.00K$ 27.00K---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -59.60M$ -68.17M$ -68.77M$ -34.12M$ -44.26M$ -16.82M
Basic EPS
$ -1.22$ -1.63$ -1.90$ -1.22$ -3.16$ -1.20
Diluted EPS
$ -1.22$ -1.63$ -1.90$ -1.22$ -3.16$ -1.20
Basic Average Shares
$ 192.73M$ 41.74M$ 36.19M$ 27.98M$ 13.99M$ 13.99M
Diluted Average Shares
$ 192.73M$ 41.74M$ 36.19M$ 27.98M$ 13.99M$ 13.99M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 69.02M$ 84.58M$ 86.52M$ 65.12M$ 53.71M$ 32.24M
Net Income From Continuing And Discontinued Operation
$ -59.60M$ -68.17M$ -68.77M$ -34.12M$ -44.26M$ -16.82M
Normalized Income
$ -41.97M$ -68.49M-$ -26.95M$ -44.26M$ -16.82M
Interest Expense
------
EBIT
$ -61.44M$ -75.42M$ -70.90M$ -34.12M$ -44.52M$ -18.49M
EBITDA
$ -60.34M$ -74.40M$ -70.15M$ -33.57M$ -44.22M$ -18.25M
Currency in USD

Ikena Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis